CSIMarket
 
Avita Medical Inc   (RCEL)
 

The company announced rather relevant deterioration in their top-line, all along the fiscal span ending September 30 2022

company reported fourth quarter of 2022 operating shortfall of $-5.908 millions


Published Mar 24 2023
CSIMarket Team / CSIMarket.com


Medical_ultrasound_examination_pdFor the July to September 30 2022 period company Diminishing Returns have swelled of $-0.22 per share compare to $-0.19 a year prior and earnings per share improved from $-0.25 per share from the prior reporting period.

Revenues decreased in double digits by -11.762 % to $9.09 millions from $10.30 millions in the same reporting period a year prior and sequentially Revenues advanced by 9.082 % from $8.34 millions.




For the July to September 30 2022 period Avita Medical Inc realized net deficit of $-5.588 million, larger than $-4.718 million a year ago.


Avita Medical Inc is expected to report next financial results on May 11, 2023.



Avita Medical Inc's Dividend Growth

Avita Medical Inc's Free Cash Flow Margin



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com